Stocktoria
Pediatrix Medical Group, Inc. MD
NYSE · XNYS · stock · Services-Hospitals · website · IPO 1995-09-20
Pediatrix Medical Group, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B |
| Operating income | $208.8M | -$68.7M | $7.3M | $172.7M | $202.9M |
| Interest expense | — | — | $42.1M | $39.7M | $68.7M |
| Income tax | $51.0M | -$2.3M | $12.0M | $18.8M | $27.2M |
| Net income | $165.4M | -$99.1M | -$60.4M | $66.3M | $131.0M |
| EPS (diluted) | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 |
| Operating cash flow | $274.7M | $217.2M | $146.1M | $182.3M | $113.8M |
| Cash & equivalents | $375.2M | $229.9M | $73.3M | $9.8M | $387.4M |
| Total assets | $2.2B | $2.2B | $2.2B | $2.3B | $2.7B |
| Total liabilities | $1.4B | $1.4B | $1.4B | $1.5B | $1.8B |
| Shareholders' equity | $865.9M | $764.9M | $849.1M | $891.6M | $896.7M |
Source: SEC EDGAR filings · CIK 0000893949 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.